Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Report: ACA premiums to jump 30%, CMS documents show
The Washington Post reported that it reviewed documents from the Centers for Medicare & Medicaid Services, confirming that the cost of medical coverage is set to spike for 17 million Americans. Open enrollment for coverage through Affordable Care Act exchanges begins on Nov. 1.
PSMA-PET imaging not the most cost-effective option for many prostate cancer patients
The exam effectively helps providers manage patients’ treatment options, but for some, the costs associated with those treatments may negate the value of its findings.
Healthcare AI today: Efficiency vs. effectiveness, ChatEHR, inspiring AI leader, more
Just because it’s efficient doesn’t mean it’s effective. Nowhere is this thought more deserving of reflection than in healthcare AI—especially when it’s applied to clinical decision support.
Radiology groups rail against additional tariffs on imaging devices
RSNA, RadNet, the RBMA and Japanese imaging leaders all recently spoke out against the possibility of more fees on device imports.
AI reveals crucial community factors influencing cancer screening rates
Neiman researchers recently scoured for factors that might impact screening rates across cancers of the colon/rectum, lung, breast and prostate, using nationwide Medicare data.

American College of Radiology partners with FDA to hasten availability of AI products

The administration is seeking greater communication between the manufacturers of breakthrough devices and physician professional societies such as the ACR.

Radiopharmaceutical firm Pentixapharm raises $22M through initial public stock offering

Founded in 2019, the firm is focused on developing products for the diagnosis and therapy of blood cancers and other indications not addressed by nuclear medicine.

Private equity firm buys controlling stake in Surescripts

TPG will not own a majority of the e-prescriber, with CVS Health and Express Scripts maintaining a minority stake.

The Texas State Capital building in Austin where 140 scope creep bills were defeated in 2024 by the Texas medical Association.

Texas sues PBMs and drug manufacturers for insulin price collusion

Two weeks ago, the FTC launched a similar antitrust suit. The pharmacy benefit managers and pharmaceutical companies are accused of artificially raising drug costs through rebates and kickbacks.

Medtronic's MiniMed 780 (left) and 670 (right) insulin pumps in FDA recall

FDA rules Medtronic’s insulin pump issues a Class I recall due to safety risks

Some of Medtronic's 600 and 700 series MiniMed insulin pumps are experiencing significant battery issues when dropped, bumped or impacted in any way. This has been linked to reports of health issues in more than 180 patients.

Home health president convicted in $1.6M Medicare and bank fraud scheme

Prosecutors said Ester Mbaya stole Medicare funds and took out lines of credit using falsified documents. She pleaded guilty to the charges.

Incidental finding characteristics that warrant communication

Three factors are associated with true high-risk findings—imaging protocols for aortic valve implantation planning, imaging area, and cardiology department orders.

Industry Watcher’s Digest

Deep fakes are more dangerous to healthcare than we may have thought.

Management

Report: ACA premiums to jump 30%, CMS documents show

PSMA-PET imaging not the most cost-effective option for many prostate cancer patients

Healthcare AI today: Efficiency vs. effectiveness, ChatEHR, inspiring AI leader, more

Radiology groups rail against additional tariffs on imaging devices

AI reveals crucial community factors influencing cancer screening rates